CURRENT Med Diag & Treatment
Guide to Internal Medicine
FreeOffers In-App Purchases
5.2.1for iPhone, iPad and more
8.9
87 Ratings
Skyscape Medpresso Inc
Developer
10.5 MB
Size
Apr 12, 2024
Update Date
Medical
Category
17+
Age Rating
Age Rating
CURRENT Med Diag & Treatment Screenshots
About CURRENT Med Diag & Treatment
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content.
The most popular, relied-upon guide to internal medicine for 60 years! Single source reference that has authoritative, evidence-based coverage of more than 1,000 diseases and disorders including concise, yet thorough synopsis of diagnosis and treatment. Written by clinicians renowned in their respective fields, this trusted classic offers expert advice on all aspects of outpatient and inpatient medical care.
The #1 annually updated general medical text—presents the most important diagnostic and treatment recommendations as well as the most useful new clinical developments in every field of adult medicine.
CURRENT Medical Diagnosis & Treatment 2024 reflects the latest developments in medicine, guidelines, references, and more. Helps students, residents, and clinicians to build their medical knowledge, expertise, and confidence.
CURRENT Medical Diagnosis & Treatment 2024 features:
- A comprehensive approach to patient care, focusing on the diagnostic tools relevant to daily practice
- Coverage of more than 1,000 diseases and disorders
- Hundreds of drug treatment tables for quick access to indexed trade names
- Annual updates to topics in all chapters in a consistent format, drugs, tables, and images
- Year in Review highlighting the many topics with significant clinical changes over the last year
- Essentials of Diagnosis for most diseases/disorders
- Diagnostic and treatment algorithms present complex information in an at-a-glance style
- Hundreds of full-color photos and illustrations
New to this edition:
- Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.
Content licensed from printed ISBN 10: 1265556032
Content licensed from printed ISBN 13: 9781265556037
SUBSCRIPTION :
Please choose an auto renewable subscription plan to receive content access & continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content.
Yearly auto-renewing payments-$64.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user & auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000
Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, Kenneth R. McQuaid, Monica Gandhi
Publisher: The McGraw-Hill Companies, Inc.
The most popular, relied-upon guide to internal medicine for 60 years! Single source reference that has authoritative, evidence-based coverage of more than 1,000 diseases and disorders including concise, yet thorough synopsis of diagnosis and treatment. Written by clinicians renowned in their respective fields, this trusted classic offers expert advice on all aspects of outpatient and inpatient medical care.
The #1 annually updated general medical text—presents the most important diagnostic and treatment recommendations as well as the most useful new clinical developments in every field of adult medicine.
CURRENT Medical Diagnosis & Treatment 2024 reflects the latest developments in medicine, guidelines, references, and more. Helps students, residents, and clinicians to build their medical knowledge, expertise, and confidence.
CURRENT Medical Diagnosis & Treatment 2024 features:
- A comprehensive approach to patient care, focusing on the diagnostic tools relevant to daily practice
- Coverage of more than 1,000 diseases and disorders
- Hundreds of drug treatment tables for quick access to indexed trade names
- Annual updates to topics in all chapters in a consistent format, drugs, tables, and images
- Year in Review highlighting the many topics with significant clinical changes over the last year
- Essentials of Diagnosis for most diseases/disorders
- Diagnostic and treatment algorithms present complex information in an at-a-glance style
- Hundreds of full-color photos and illustrations
New to this edition:
- Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.
Content licensed from printed ISBN 10: 1265556032
Content licensed from printed ISBN 13: 9781265556037
SUBSCRIPTION :
Please choose an auto renewable subscription plan to receive content access & continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content.
Yearly auto-renewing payments-$64.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user & auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000
Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, Kenneth R. McQuaid, Monica Gandhi
Publisher: The McGraw-Hill Companies, Inc.
Show More
What's New in the Latest Version 5.2.1
Last updated on Apr 12, 2024
Old Versions
- Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
Show More
Version History
5.2.1
Apr 12, 2024
- Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions
5.1.2
Jan 30, 2024
Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
5.1.1
Sep 21, 2023
Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access
5.0.10
Mar 28, 2023
NEW TO THIS EDITION
- Ongoing concerted effort to address and remove unconscious bias
- List of Common Abbreviations used in CMDT
- New section on opioids for pain management
- Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions
- Expanded section of interventional therapies to manage chronic pain
- Updated USPSTF lung cancer screening recommendations using low-dose CT
- New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2
- Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy
- Updated section on osmotic laxatives to treat chronic constipation
- Ozanimod approved for the treatment of moderate to severe ulcerative colitis
- Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage
- New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib)
- New recommendations on treating cholestasis of pregnancy
- Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement
- New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab
- Anifrolumab is approved for nonrenal lupus when standard therapies fail
- New guidelines for diagnosing polyarteritis nodosa
- New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis
- A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis
- Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization
- Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease
- Extensive revision of the Thyroiditis section in Endocrine Disorders topic
- Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic
- Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens
- Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook
- Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons
- Ongoing concerted effort to address and remove unconscious bias
- List of Common Abbreviations used in CMDT
- New section on opioids for pain management
- Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions
- Expanded section of interventional therapies to manage chronic pain
- Updated USPSTF lung cancer screening recommendations using low-dose CT
- New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2
- Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy
- Updated section on osmotic laxatives to treat chronic constipation
- Ozanimod approved for the treatment of moderate to severe ulcerative colitis
- Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage
- New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib)
- New recommendations on treating cholestasis of pregnancy
- Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement
- New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab
- Anifrolumab is approved for nonrenal lupus when standard therapies fail
- New guidelines for diagnosing polyarteritis nodosa
- New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis
- A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis
- Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization
- Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease
- Extensive revision of the Thyroiditis section in Endocrine Disorders topic
- Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic
- Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens
- Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook
- Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons
5.0.6
Feb 24, 2022
- Minor bug fixes.
5.0.3
May 27, 2021
NEW Lower Price Purchase Options
5.0.1
Apr 9, 2021
- Split Screen view for Mac and iPad
- Dark Mode
- Dark Mode
4.3.2
Jun 4, 2020
Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above
4.0
Jul 11, 2019
Critical Medical Content Update, Bug fixes and New UI/UX
3.1.3
Feb 14, 2018
- UI/UX enhancements
- Minor bug fixes
- Minor bug fixes
2.1.0
Dec 29, 2017
CURRENT Med Diag & Treatment FAQ
Click here to learn how to download CURRENT Med Diag & Treatment in restricted country or region.
Check the following list to see the minimum requirements of CURRENT Med Diag & Treatment.
iPhone
Requires iOS 12.0 or later.
iPad
Requires iPadOS 12.0 or later.
Mac
Requires macOS 10.15 or later.
iPod touch
Requires iOS 12.0 or later.
CURRENT Med Diag & Treatment supports English
CURRENT Med Diag & Treatment contains in-app purchases. Please check the pricing plan as below:
Curr Med Diag Treatment 1Y Sub
$64.99
Curr Med Diag Treatment 3M Sub
$37.99
Curr Med Diag Treatment 6M Sub
$49.99
Curr Med Diag Treat 1Y Sub Off
$47.99
Curr Med Diag Treat 15%off Sub
$55.99
Curr Med Diag Treat 20%off Sub
$51.99
Curr Med Diag Treat 25%off Sub
$48.99
Curr Med Diag Treat 25%off Sub
$44.99
Curr Med Diag Treat 20%off Sub
$47.99
Curr Med Diag Treat 15%off Sub
$50.99
Related Videos
Latest introduction video of CURRENT Med Diag & Treatment on iPhone
